Who has invested in Apertura Gene Therapy?

Deerfield Management Company are named among the investors backing Apertura Gene Therapy.

Apertura Gene Therapy Funding: $67M Raised, Series A (2022)

Apertura Gene Therapy funding overview

Apertura Gene Therapy is based in New York, NY. Apertura Gene Therapy has raised $67M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in April 2022. The round record for Apertura Gene Therapy runs through 2022; nothing later has been disclosed. Investors on record include Deerfield Management Company.

Apertura Gene Therapy at a glance

Total raised: $67M
Latest round: Series A
Latest round date: April 2022
Headquarters: New York, NY
Notable investors: Deerfield Management Company

Frequently asked about Apertura Gene Therapy funding

How much has Apertura Gene Therapy raised?: Apertura Gene Therapy has raised $67M in total disclosed funding across the rounds on record.
Who has invested in Apertura Gene Therapy?: Deerfield Management Company are named among the investors backing Apertura Gene Therapy.
What was the latest Apertura Gene Therapy funding round?: The most recent disclosed round is a Series A, announced in April 2022.
Where is Apertura Gene Therapy based?: Apertura Gene Therapy is based in New York, NY.
When did Apertura Gene Therapy last raise?: The last disclosed Apertura Gene Therapy round closed in April 2022 at Series A.

Every Apertura Gene Therapy figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in New York at a similar stage.

Apertura Gene Therapy Funding: $67M Raised, Series A (2022)

Apertura Gene Therapy funding overview

Apertura Gene Therapy at a glance

Frequently asked about Apertura Gene Therapy funding

Companies related to Apertura Gene Therapy (29)

Browse related funding lists (6)